EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Cervical Cancer in Women With HIV: A Call to Action for Equitable Prevention in Low‐ and Middle‐Income Countries

Jonathan Klutse iD, Yeena Abla Tay iD, Dzidzor Aku Attoh iD, Emmanuel Frimpong Gyekye iD, Charlotte Borteley Bortey, Esenam Dzifa Buatsi iD, Charlayne Cherylyn Oppong iD, Helena Lamptey iD, Collins Stephen Ahorlu iD, George Boateng Kyei iD, Evelyn Yayra Bonney iD

BioMed Research International · 2025

DOI: 10.1155/bmri/1711050 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift BioMed Research International, 2025. Verfasst von Jonathan Klutse und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Virology, Noguchi Memorial Institute for Medical Research, University of Ghana, Accra, Ghana, ug.edu.gh. Hauptthemen laut MEDLINE: Uterine Cervical Neoplasms, HIV Infections. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 66 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIAID NIH HHS, Expertise France, National Institute of Allergy and Infectious Diseases.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Cervical cancer is preventable; however, it remains the leading cause of death in low‐ and middle‐income countries (LMICs). Women with HIV (WWHs) have a sixfold higher risk of developing and dying from cervical cancer than women without HIV. Cervical cancer can be prevented by vaccination against high‐risk human papillomaviruses (hrHPVs) and by screening for and treating precancer cervical lesions. While these preventive measures are routinely available to WWHs in developed countries, they are lacking in most LMICs, where the burden of HIV and cervical cancer is the highest. To prevent cervical cancer deaths among WWHs in LMICs, it is imperative to determine the dual burden of HIV and cervical cancer in LMICs. This narrative review synthesized scientific papers and policy documents on the intersection of HIV and cervical cancer in LMICs published between August 2006 and July 2025. We searched PubMed, Scopus, Web of Science, and Google Scholar for articles and official reports from the World Health Organization (WHO) and the US Centers for Disease Control and Prevention (CDC) on cervical cancer burden, prevention strategies, barriers, and outcomes among WWHs. Despite its proven effectiveness, HPV vaccination coverage in LMICs is under 30%, and screening uptake is below 20%. Weak health systems, workforce shortages, stigma, reliance on donor funding, and late‐stage case presentation are major challenges in curbing cervical cancer in LMICs. Urgent political commitment is required to integrate precancer screening and HPV testing into routine HIV care and scale‐up HPV vaccination to achieve the WHO′s triple‐intervention targets to eliminate cervical cancer among WWHs in LMICs.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Uterine Cervical NeoplasmsHIV InfectionsHumansFemaleDeveloping CountriesPapillomavirus InfectionsPapillomavirus VaccinesEarly Detection of Cancer

Stichwörter der Autor:innen

HIVHPV DNAcervical cancercervical cancer screeninghuman papillomavirus

Substanzen

Papillomavirus Vaccines

Autor:innen und Institutionen

  • Department of Virology, Noguchi Memorial Institute for Medical Research, University of Ghana, Accra, Ghana, ug.edu.gh.
  • Department of Immunology, Noguchi Memorial Institute for Medical Research, University of Ghana, Accra, Ghana, ug.edu.gh.
  • Department of Epidemiology, Noguchi Memorial Institute for Medical Research, University of Ghana, Accra, Ghana, ug.edu.gh.
  • Medical and Scientific Research Centre, University of Ghana Medical Centre, Accra, Ghana, ugmedicalcentre.org.
  • Department of Medicine and Molecular Microbiology, Washington University in St. Louis, St. Louis, Missouri, USA, wustl.edu.

ORCID-Profile: Jonathan Klutse, Yeena Abla Tay, Dzidzor Aku Attoh, Emmanuel Frimpong Gyekye, Esenam Dzifa Buatsi, Charlayne Cherylyn Oppong, Helena Lamptey, Collins Stephen Ahorlu, George Boateng Kyei, Evelyn Yayra Bonney

Förderung

  • NIAID NIH HHS
  • Expertise France
  • National Institute of Allergy and Infectious Diseases
  • National Institutes of Health

Zitieren

APA

Klutse, J., Tay, Y. A., Attoh, D. A., Gyekye, E. F., Bortey, C. B., Buatsi, E. D., Oppong, C. C., Lamptey, H., Ahorlu, C. S., Kyei, G. B., & Bonney, E. Y. (2025). Cervical Cancer in Women With HIV: A Call to Action for Equitable Prevention in Low‐ and Middle‐Income Countries. BioMed Research International. https://doi.org/10.1155/bmri/1711050

Vancouver

Klutse J, Tay YA, Attoh DA, Gyekye EF, Bortey CB, Buatsi ED, et al. Cervical Cancer in Women With HIV: A Call to Action for Equitable Prevention in Low‐ and Middle‐Income Countries. BioMed Research International. 2025. doi:10.1155/bmri/1711050

BibTeX
@article{Klutse2025,
  author = {Klutse, Jonathan and Tay, Yeena Abla and Attoh, Dzidzor Aku and Gyekye, Emmanuel Frimpong and Bortey, Charlotte Borteley and Buatsi, Esenam Dzifa and Oppong, Charlayne Cherylyn and Lamptey, Helena and Ahorlu, Collins Stephen and Kyei, George Boateng and Bonney, Evelyn Yayra},
  title = {Cervical Cancer in Women With HIV: A Call to Action for Equitable Prevention in Low‐ and Middle‐Income Countries},
  journal = {BioMed Research International},
  year = {2025},
  doi = {10.1155/bmri/1711050}
}
Kostenlos starten →